Title : Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma.

Pub. Date : 2020 Mar-Apr

PMID : 32521890






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Compared with TACE alone, Sorafenib combined with TACE can significantly improve ORR and DCR, obviously reduce the levels of serum VEGF, bFGF and AFP, and prolong the survival of patients with advanced hepatocellular carcinoma, while the adverse reactions are tolerable, so it is worthy of clinical popularization and application. Sorafenib alpha fetoprotein Homo sapiens